Ss&C Technologies Holdings, Inc.
$26.60B- Market cap
- $19.63B
- Debt
- +$7.43B
- Cash
- −$462.10M
Capital structure 73% equity / 27% debt · EV / Revenue 4.24x · EV / EBITDA 10.48x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: SSNC stock price vs OFIX: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at OFIX's multiple
Needs OFIX P/E.
Implied fair value · at SSNC's multiple
Needs EPS (TTM) is negative, SSNC P/E.
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Multiple premium
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: SSNC FY 2025 (ended Dec 31, 2025) · OFIX FY 2025 (ended Dec 31, 2025).
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 73% equity / 27% debt · EV / Revenue 4.24x · EV / EBITDA 10.48x
Capital structure 71% equity / 29% debt · EV / Revenue 0.55x · EV / EBITDA 119.73x
SSNC carries the larger enterprise value at $26.60B against $453.77M; OFIX trades on the lower EV / Revenue multiple (0.55x vs 4.24x); SSNC on the lower EV / EBITDA (10.48x vs 119.73x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
SS&C TECHNOLOGIES HOLDINGS, INC. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Orthofix Medical Inc. · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
1.08x
0.35x
Net debt / EBITDA
Leverage against operating earnings
2.75x
19.89x
Cash and equivalents
Liquid reserves on the balance sheet
$462.10M
$82.03M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Fidelity National Information Services, Inc.
SSNC vs FIS
BROADRIDGE FINANCIAL SOLUTIONS, INC.
SSNC vs BR
JACK HENRY & ASSOCIATES INC
SSNC vs JKHY
Morningstar, Inc.
SSNC vs MORN
IonQ, Inc.
SSNC vs IONQ
STRYKER CORP
SSNC vs SYK
ZIMMER BIOMET HOLDINGS, INC.
SSNC vs ZBH
Medtronic plc
SSNC vs MDT
Johnson & Johnson
SSNC vs JNJ
$7.43B
$157.39M
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.